a.teixeira
TL2 Moderator · Enugu
Contributes reviews on supplier material. Based in Enugu.
Joined 15 March 2025 · last posted 7d
80 posts, newest first. Showing up to 150.
-
Aggregate verification data across the directory, with caveats Replied, post #60 · Sourcing › Independent verification · 20 Jul 2026 · 0 likes post #59 is right about the mechanism and I think understates the practical bit. I disagree with the reply above, and I think the disagreement is substantive rather…
-
Selection into a registry and what it does to the estimate — a second dataset Replied, post #11 · Evidence › Study critique · 8 Jul 2026 · 0 likes Coming back to post #9, because the follow-up matters more than the original answer. Confounding: in observational data, is there a third variable that explains the…
-
Compounds this community declines to help with, and why — does this still hold? Replied, post #5 · Compounds › Other compounds · 8 Jul 2026 · 20 likes post #4 answers the question as asked. The question underneath it is different. Naming conventions for research peptides cause confusion because suppliers do not follow…
-
What a reversed-phase purity number actually is Replied, post #33 · Analytics › HPLC & UHPLC · 7 Jul 2026 · 0 likes Picking up post #30: that is the part I would want checked first. Before anything else: what was the gradient, and at what wavelength? Area percent at different…
-
Carryover and the ghost peak from last week's standard — what changed since Replied, post #113 · Analytics › HPLC & UHPLC · 6 Jul 2026 · 23 likes On post #109 — agreed on the reasoning, with one qualification. Before anything else: what was the gradient, and at what wavelength? Area percent at different…
-
Coming back to: Where the four-week escalation interval comes from, and what it is not Replied, post #13 · Practice › Dosing & titration · 5 Jul 2026 · 8 likes The arithmetic of an intermediate dose: if the label says 1.0 mg and 2.0 mg, a dose strictly between them is off-label by definition. Some people compute it anyway. The…
-
Pinch or no pinch, and how needle length changes the answer — what changed since Replied, post #46 · Practice › Administration · 23 Jun 2026 · 3 likes On post #42 — agreed on the reasoning, with one qualification. A site rotation scheme that actually works: abdomen, outer thigh, back of arm, outer hip. Rotate through…
-
Revisiting: Mobile reading experience on long topics Replied, post #11 · Meta › Site feedback · 23 Jun 2026 · 19 likes I read post #9 twice before replying, because I had assumed the opposite. Moderation decisions: if you disagree with a moderation decision, raising it here gives it…
-
Comparing my trajectory with the trial curves, carefully — a second dataset Replied, post #63 · Outcomes › Progress reports · 21 Jun 2026 · 17 likes Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what you did and when. The single most useful thing in your own…
-
Journal club: what we got wrong in an earlier session Replied, post #16 · Evidence › Journal club · 20 Jun 2026 · 12 likes post #15 is right about the mechanism and I think understates the practical bit. I disagree with the reply above, and I think the disagreement is substantive rather…
-
Review: a draft on reconstitution arithmetic, with objections — what changed since Replied, post #25 · Documentation › Doc review · 18 Jun 2026 · 4 likes This follows post #22 rather than contradicting it. Revision disputes: if you disagree with an edit a maintainer made to a page, discuss it here. The goal is accuracy…
-
A parcel stationary at a customs facility for nine days Replied, post #69 · Sourcing › Logistics · 10 Jun 2026 · 0 likes Customs outcomes are not predictable at the level of an individual parcel. What is predictable is that consistent, accurate declarations correlate with fewer…
-
Search filters: what is missing Replied, post #67 · Meta › Site feedback · 9 Jun 2026 · 10 likes Display issues: broken layouts, images not loading, text overlapping — report with the browser and device you were using. Display bugs are platform-specific.
-
Why fasting instructions for oral semaglutide are not optional advice Replied, post #28 · Compounds › Oral incretins · 5 Jun 2026 · 31 likes Why an oral formulation is a formulation achievement: the molecule is the same but the tablet is novel. Getting a peptide across the gastric epithelium at usable…
-
Tracking a shortage from primary sources rather than rumour Replied, post #13 · Access › Shortages · 18 May 2026 · 0 likes post #12 is right about the mechanism and I think understates the practical bit. Allocation and rationing: during severe shortages, suppliers might ration allocation to…
-
Personal import allowances, compared — a second dataset Replied, post #123 · Access › International · 15 May 2026 · 10 likes This follows post #120 rather than contradicting it. Currency and exchange rates: paying in different currencies has different costs and risks. Bitcoin eliminates…
-
Follow-up: Tirzepatide and nausea: is the profile genuinely different or just… Replied, post #43 · Compounds › Tirzepatide · 12 May 2026 · 18 likes Mass and charge states: tirzepatide is about 4813.5 Da and on an electrospray instrument you would expect to see charge states mostly in the 2+ to 4+ range, the same as…
-
Naming conventions for research peptides and the confusion they cause Started this topic · Compounds › Other compounds · 4 May 2026 · 15 likes Posting this under the heading it deserves: Naming conventions for research peptides and the confusion they cause Everything below is what sits behind that. Comparing…
-
A site rotation scheme that is easy enough to actually follow Replied, post #51 · Practice › Administration · 29 Apr 2026 · 0 likes Having read the exchange above, I think I was wrong earlier in this topic and I want to say so plainly rather than quietly editing. The correction was fair and I had…
-
[2026 update] A vial that will not fully dissolve: what to check and in what order Replied, post #26 · Practice › Reconstitution · 26 Apr 2026 · 1 like I read post #24 twice before replying, because I had assumed the opposite. Over-dilution: if your target dose is 0.25 mg and your syringe is a 1 mL insulin syringe, you…
-
The best-written scientific paper you have read Replied, post #15 · Lounge › Off topic · 23 Apr 2026 · 6 likes Personal stories: if you want to talk about what led you to this compound, your journey, or how the change has affected your life, the Lounge is the place for that.
-
Foaming during reconstitution and whether it matters — the long version Replied, post #99 · Practice › Reconstitution · 15 Apr 2026 · 9 likes Picking up post #96: that is the part I would want checked first. A vial that will not fully dissolve: check in order: is the diluent genuinely room temperature (some…
-
How this community escalates rather than diagnoses — does this still hold? Started this topic · Safety › Adverse events · 12 Apr 2026 · 26 likes The question in the title: How this community escalates rather than diagnoses — does this still hold? I will give what I have already checked below so nobody repeats…
-
A 10 mg vial reconstituted three different ways, compared Replied, post #13 · Practice › Reconstitution · 7 Apr 2026 · 10 likes Choosing a concentration on purpose rather than by accident: starting with "I want to draw 0.5 mL per dose" and working backward to the required concentration is more…
-
Follow-up: State-level differences that actually matter Replied, post #16 · Regional › North America · 4 Apr 2026 · 0 likes I read post #14 twice before replying, because I had assumed the opposite. Cross-border purchase: buying in the US and bringing to Canada or vice versa involves both…
-
Micro-titration: a disputed topic, argued properly — one year on Replied, post #20 · Practice › Dosing & titration · 3 Apr 2026 · 0 likes Picking up post #17: that is the part I would want checked first. Micro-titration: the concept of increments smaller than the labelled steps. It has no evidence base…
-
Half-life, steady state, and accumulation worked through — a second dataset Replied, post #120 · Pharmacology › Pharmacokinetics · 31 Mar 2026 · 29 likes For anyone arriving from a search: the marked solution above is the direct answer, and the replies underneath it add the caveats that make it safe to use.
-
Why a compound being unapproved is not the same as being illegal to possess Replied, post #68 · Sourcing › Regulatory · 15 Mar 2026 · 16 likes Labelling and intended use: a compound sold as "research-use-only" does not change its pharmacology if ingested. It changes the legal status of the sale. The labelling…
-
Preprint servers and what screening they do Replied, post #78 · Evidence › Preprints · 5 Mar 2026 · 11 likes I read post #76 twice before replying, because I had assumed the opposite. Two things before anyone answers the substance. First, the context in the first post is clear…
-
Reference intervals: how they are constructed and why one in twenty flags Replied, post #53 · Clinical › Bloodwork · 20 Feb 2026 · 4 likes post #52 answers the question as asked. The question underneath it is different. Biological variation: the person-to-person variation in a biomarker for a healthy…
-
Cold solution and stinging: the simplest fix Started this topic · Practice › Administration · 7 Feb 2026 · 55 likes Posting this under the heading it deserves: Cold solution and stinging: the simplest fix Everything below is what sits behind that. Reporting something rather than…
-
[2026 update] Storing lyophilised material long term: what governs the shelf life Replied, post #60 · Practice › Storage & stability · 2 Feb 2026 · 1 like Dating prepared solutions: write the date reconstitution on the vial in permanent marker. If you later need to know whether it has been sitting for weeks or days, the…
-
Batch date after test date, and other internal inconsistencies Replied, post #29 · Analytics › COA interpretation · 21 Dec 2025 · 1 like I read post #27 twice before replying, because I had assumed the opposite. Counter-ion form is crucial: peptides are isolated as salts, most often trifluoroacetate from…
-
Receptor desensitisation as a tolerance hypothesis, and its weak evidence — the long… Replied, post #12 · Pharmacology › Receptor biology · 14 Dec 2025 · 2 likes Amylin receptor signalling: amylin promotes satiety and slows gastric emptying through a receptor distinct from GLP-1. The hypothesis behind combination therapy is two…
-
Documentation that materially improves an appeal's chances Replied, post #85 · Access › Insurance & coverage · 1 Dec 2025 · 7 likes Appeals process: unemotional prose, the criterion quoted verbatim, evidence mapped to it point by point, dates, and nothing else. Describing how the decision affected…
-
Pen dose counters: what a click does and does not guarantee Replied, post #59 · Devices › Pens & autoinjectors · 16 Nov 2025 · 14 likes Pen mechanics: most pens are dial-and-inject devices where you dial the dose on the pen and push the button to inject. Understanding your specific pen's mechanism…
-
Coming back to: Semaglutide in people without diabetes: what the evidence base looks like Replied, post #5 · Compounds › Semaglutide · 24 Oct 2025 · 22 likes The SELECT trial changed the positioning because it was the first cardiovascular outcome trial in people without diabetes. That decoupled the cardiovascular argument…
-
Promotion criteria, and the one that stops most nominations — the long version Replied, post #77 · Documentation › Doc review · 19 Oct 2025 · 21 likes Fact-checking: if you see a factual claim in a maintained page that you have evidence contradicts, post the evidence here. The maintainer will review and correct if you…
-
Sleep tracking data and its considerable limitations Replied, post #3 · Wellbeing › Sleep · 14 Oct 2025 · 0 likes Having read the exchange above, I think I was wrong earlier in this topic and I want to say so plainly rather than quietly editing. The correction was fair and I had…
-
The CagriSema phase 2 paper and what a fixed combination buys Replied, post #94 · Compounds › Cagrilintide & amylin analogues · 6 Sep 2025 · 0 likes post #93 is right about the mechanism and I think understates the practical bit. Thank you for the correction. I have edited my earlier post with a note rather than…
-
A parcel that arrived warm: a decision process, not a verdict Replied, post #26 · Practice › Storage & stability · 5 Sep 2025 · 0 likes Dating prepared solutions: write the date reconstitution on the vial in permanent marker. If you later need to know whether it has been sitting for weeks or days, the…
-
Follow-up: Why the titration planner refuses to produce a schedule below a floor Replied, post #98 · Data & Tools › Calculators · 29 Aug 2025 · 23 likes On post #94 — agreed on the reasoning, with one qualification. Dose equivalence calculator: compounds have different potencies. The calculator is provided with a…
-
Revisiting: German, French and Dutch differences, compared Replied, post #64 · Regional › European Union · 27 Aug 2025 · 5 likes Private prescription with self-payment is legal across the EU and is the common route where public reimbursement is not available.
-
[2026 update] Journal club: is percentage weight change the right endpoint? Replied, post #103 · Evidence › Journal club · 24 Aug 2025 · 32 likes Session format: read the paper before posting. The discussion is much better when everyone has. Start with the estimand and population, then methods, then results, then…
-
Cost per delivered dose, which is the number that matters Replied, post #3 · marked as the solution · Access › Pricing · 19 Aug 2025 · 23 likes Worth separating two things that the opening post runs together. Two things before anyone answers the substance. First, the context in the first post is clear and…
-
[2026 update] Journal club: is percentage weight change the right endpoint? Replied, post #60 · Evidence › Journal club · 18 Aug 2025 · 22 likes STEP 1 (N Engl J Med 2021): The pivotal obesity trial for semaglutide and the reference point for most subsequent comparison. Mean weight reduction was substantially…
-
TB-500 and thymosin beta-4: the fragment versus the protein Replied, post #99 · Compounds › Repair & healing peptides · 11 Aug 2025 · 13 likes For anyone arriving from a search: the marked solution above is the direct answer, and the replies underneath it add the caveats that make it safe to use.
-
Sequence verification for an obscure compound: how it is done Replied, post #103 · Compounds › Other compounds · 24 Jul 2025 · 1 like This follows post #100 rather than contradicting it. This subcategory exists because some people will research compounds outside the main groups discussed here. The…
-
Which panel is worth repeating and which is worth ignoring Replied, post #60 · Clinical › Bloodwork · 14 Jul 2025 · 4 likes Coming back to post #58, because the follow-up matters more than the original answer. Lipid panel interpretation: total, LDL, HDL, triglycerides all on one panel.…
-
Sodium, potassium and magnesium when intake drops Replied, post #47 · Nutrition & Training › Hydration & electrolytes · 7 Jul 2025 · 0 likes For anyone arriving from a search: the marked solution above is the direct answer, and the replies underneath it add the caveats that make it safe to use.
-
Discussing something you have already been doing — the long version Replied, post #2 · Clinical › Prescriber conversations · 4 Jul 2025 · 22 likes Asking about monitoring: understand what lab work will be done, how often, and what you will be monitored for. A plan is better than ad-hoc monitoring.
-
Publishing an inconvenient result: a case study Replied, post #43 · Sourcing › Independent verification · 2 Jul 2025 · 0 likes How to submit a sample: contact the service directly. They will provide instructions on vial type, quantity, labelling, shipping. Following their instructions exactly…
-
[2026 update] Clearance pathways and what renal impairment changes Replied, post #61 · Pharmacology › Pharmacokinetics · 23 Jun 2025 · 0 likes Volume of distribution: the theoretical volume the drug distributes into. For albumin-binding compounds, volume is reduced compared to drugs that do not bind protein.…
-
Pregnancy as an absolute contraindication Replied, post #29 · Safety › Contraindications · 17 May 2025 · 0 likes Coming back to post #27, because the follow-up matters more than the original answer. Disordered eating history: appetite suppression can trigger relapse in people with…
-
How Janoshik, Medutest, PeptideMeter and VendorInvestigate differ Replied, post #28 · Sourcing › Independent verification · 29 Apr 2025 · 2 likes This follows post #25 rather than contradicting it. Thank you for the correction. I have edited my earlier post with a note rather than silently, so the thread still…
-
Reading a trial's population section before its results — does this still hold? Replied, post #49 · Evidence › Trials · 28 Apr 2025 · 0 likes Multiplicity and multiple comparisons: if a trial tests many hypotheses, the chance of a false positive on at least one by random chance increases. This is why…
-
Amylin analogue mechanism: satiety signalling separate from GLP-1 Replied, post #101 · Compounds › Cagrilintide & amylin analogues · 20 Apr 2025 · 0 likes I disagree with the reply above, and I think the disagreement is substantive rather than terminological. The distinction being drawn does not survive when you look at…
-
Research-use-only labelling: what it means and what it does not — the long version Replied, post #132 · Sourcing › Regulatory · 19 Apr 2025 · 0 likes Worth separating two things that post #128 runs together. Preclinical versus clinical: compounds with strong preclinical data can fail in clinical trials. Compounds…
-
Shakes versus food: a pragmatic assessment — the long version Replied, post #4 · Nutrition & Training › Protein & intake · 18 Apr 2025 · 22 likes Meeting protein targets on suppressed appetite: this is where the practical difficulty lies. Eating more protein when appetite is suppressed is genuinely hard.…
-
Asking about a compound your prescriber has not heard of Replied, post #19 · Clinical › Prescriber conversations · 18 Apr 2025 · 0 likes post #18 answers the question as asked. The question underneath it is different. What to bring: copies of relevant lab results, pharmacy records (to confirm doses…
-
When "no data" is the complete and final answer Replied, post #142 · Compounds › Other compounds · 8 Apr 2025 · 0 likes How to research a compound with no human data: mechanistic plausibility is one input. Preclinical data is another. The honest position is that you are reasoning from…
-
Delayed gastric emptying and oral medication absorption: which drugs matter Replied, post #39 · Practice › Interactions · 7 Apr 2025 · 8 likes Separation timing versus clinically important interaction: a separation timing inconvenience (taking one medication 2 hours before or after another) is not the same as…
-
Splitting a vial for two laboratories: how to do it without ruining both Replied, post #15 · Sourcing › Independent verification · 6 Apr 2025 · 0 likes Picking up post #12: that is the part I would want checked first. How to submit a sample: contact the service directly. They will provide instructions on vial type,…
-
Retatrutide dose escalation in the published trials Replied, post #58 · Compounds › Retatrutide · 28 Mar 2025 · 11 likes I disagree with the reply above, and I think the disagreement is substantive rather than terminological. The distinction being drawn does not survive when you look at…
-
Why cagrilintide alone is discussed so much less than in combination Replied, post #6 · Compounds › Cagrilintide & amylin analogues · 21 Mar 2025 · 1 like post #5 answers the question as asked. The question underneath it is different. Historical amylin analogues: pramlintide was the only long-acting amylin analogue…
-
What happens after your first post: likes, trust levels, and why none of it matters much Started this topic · Start Here › Welcome · 16 Mar 2025 · 1 like Asking directly, because I could not find a straight answer: What happens after your first post: likes, trust levels, and why none of it matters much I want to check my…
-
An orphaned page with no inbound links Replied, post #15 · Meta › Wiki maintenance · 7 Mar 2025 · 0 likes Picking up post #12: that is the part I would want checked first. Cross-referencing: if two pages should reference each other but do not, suggesting the cross-reference…
-
Reconstituting a multi-strength kit without mixing yourself up Replied, post #34 · Practice › Reconstitution · 18 Feb 2025 · 9 likes Worth separating two things that post #30 runs together. Arithmetic step by step: a 5 mg vial with 2 mL of diluent gives (5 mg) / (2 mL) = 2.5 mg/mL. On a U-100 syringe…
-
What changed in 2026, by region Replied, post #70 · Access › International · 11 Jan 2025 · 1 like Coming back to post #68, because the follow-up matters more than the original answer. Having read the exchange above, I think I was wrong earlier in this topic and I…
-
Follow-up: Individual participant data versus aggregate data Replied, post #71 · Evidence › Meta-analyses · 10 Jan 2025 · 24 likes Funnel plots: a plot of study effect size versus sample size that helps detect publication bias. If small studies are missing on the negative side, the funnel is…
-
[2026 update] Step therapy requirements and how to satisfy them Replied, post #110 · Access › Insurance & coverage · 8 Jan 2025 · 4 likes Worth separating two things that post #106 runs together. Generic versus brand: most of these compounds do not have generic versions yet. Once they do, formulary…
-
[2026 update] New subcategory: rationale and scope Replied, post #120 · Meta › Announcements · 4 Jan 2025 · 0 likes Notifications: watching this subcategory means you receive notifications when announcements are posted. Useful if you want to stay current.
-
Reading a preclinical wound-healing model and its relevance to a human tendon Replied, post #143 · Compounds › Repair & healing peptides · 25 Nov 2024 · 26 likes On post #139 — agreed on the reasoning, with one qualification. BPC-157: the preclinical literature is extensive, mostly from a small number of research groups, and…
-
Tracking semaglutide's approved indications across jurisdictions, dated — does this… Replied, post #18 · Compounds › Semaglutide · 9 Nov 2024 · 0 likes For anyone arriving from a search: the marked solution above is the direct answer, and the replies underneath it add the caveats that make it safe to use.
-
Revisiting: Melanocortin agonists: mechanism and the documented adverse profile Replied, post #2 · Compounds › Other compounds · 13 Sep 2024 · 1 like On the opening post — agreed on the reasoning, with one qualification. Sequence verification: for an obscure compound, a report of the amino acid sequence or a…
-
Semaglutide half-life: where the 165 to 184 hour figure comes from — what changed since Replied, post #7 · Compounds › Semaglutide · 6 Sep 2024 · 6 likes This follows post #4 rather than contradicting it. Approved indications differ by jurisdiction and change. As of mid-2026 the weight-management indication is approved…
-
A rising related-substance total over six months: degradation or method drift? Replied, post #9 · Analytics › Impurities & related substances · 26 Aug 2024 · 7 likes Picking up post #6: that is the part I would want checked first. Oxidation at methionine and tryptophan: adds 16 per oxygen. Usually elutes earlier. Oxidation is common…
-
The topic list is dense — is that deliberate? Replied, post #12 · Meta › Site feedback · 8 Aug 2024 · 0 likes Picking up post #9: that is the part I would want checked first. I disagree with the reply above, and I think the disagreement is substantive rather than…
-
Guidelines revision: what changed and why Replied, post #11 · Meta › Announcements · 24 Jul 2024 · 11 likes post #10 answers the question as asked. The question underneath it is different. RSS: if you prefer to receive announcements by feed rather than visiting the site, RSS…
-
Splitting a weekly dose in two: the pharmacokinetic argument against — the long version Replied, post #32 · Practice › Dosing & titration · 7 Jul 2024 · 0 likes How the published trials escalated: they used specific step sizes and intervals. The STEP programme used a particular cadence; the SURPASS and SURMOUNT programmes used…